title: Multiple Dimensions of Value: Evaluative Frameworks for New Cancer Therapies.
authors.affiliation: Canadian Agency for Drugs and Technology in Health, Sunnybrook Health Sciences Centre, and University of Toronto, Toronto, Ontario, Canada matthew.cheung@sunnybrook.ca.
authors.forename: Matthew C
authors.initials: MC
authors.lastname: Cheung
authors.affiliation: Canadian Agency for Drugs and Technology in Health, Toronto, Ontario, Canada.
authors.forename: Mona
authors.initials: M
authors.lastname: Sabharwal
authors.affiliation: Canadian Agency for Drugs and Technology in Health, Toronto, Ontario, Canada.
authors.forename: Alexandra
authors.initials: A
authors.lastname: Chambers
authors.affiliation: Canadian Agency for Drugs and Technology in Health, Toronto, Ontario, Canada.
authors.forename: Dolly
authors.initials: D
authors.lastname: Han
authors.affiliation: Canadian Agency for Drugs and Technology in Health, Toronto, Ontario, Canada.
authors.forename: Kelley-Anne
authors.initials: KA
authors.lastname: Sabarre
authors.affiliation: Canadian Agency for Drugs and Technology in Health, Sunnybrook Health Sciences Centre, Canadian Centre for Applied Research in Cancer Control, and University of Toronto, Toronto, Ontario, Canada.
authors.forename: Kelvin
authors.initials: K
authors.lastname: Chan
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D016527:Drug Costs; D015507:Drugs, Investigational / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use*; D006801:Humans; D018803:Models, Economic; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics*; D018579:Patient Selection; D011788:Quality of Life; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational